These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17670929)

  • 1. First isolations of Segniliparus rugosus from patients with cystic fibrosis.
    Butler WR; Sheils CA; Brown-Elliott BA; Charles N; Colin AA; Gant MJ; Goodill J; Hindman D; Toney SR; Wallace RJ; Yakrus MA
    J Clin Microbiol; 2007 Oct; 45(10):3449-52. PubMed ID: 17670929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segniliparus rugosus infection, Australia.
    Hansen T; Van-Kerckhof J; Jelfs P; Wainwright C; Ryan P; Coulter C
    Emerg Infect Dis; 2009 Apr; 15(4):611-3. PubMed ID: 19331748
    [No Abstract]   [Full Text] [Related]  

  • 3. First case of Segniliparus rotundus pneumonia in a patient with bronchiectasis.
    Koh WJ; Choi GE; Lee SH; Park YK; Lee NY; Shin SJ
    J Clin Microbiol; 2011 Sep; 49(9):3403-5. PubMed ID: 21752969
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Zurita J; Sevillano G; González C; Lascano Y
    New Microbes New Infect; 2020 May; 35():100668. PubMed ID: 32461807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis.
    Moore ZS; Jerris RC; Hilinski JA
    J Cyst Fibros; 2008 May; 7(3):206-9. PubMed ID: 17719856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.
    Ho SA; Lee TW; Denton M; Conway SP; Brownlee KG
    J Cyst Fibros; 2009 Jan; 8(1):43-6. PubMed ID: 18829398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Case of Segniliparus rugosus Pulmonary Infection in an Immunocompetent Patient with Non-cystic Fibrosis.
    Lee JY; Chon GR; Jung TY; Sung H; Shim TS; Jo KW
    Tuberc Respir Dis (Seoul); 2014 Nov; 77(5):227-9. PubMed ID: 25473412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
    Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocardia farcinica isolated from bronchoalveolar lavage fluid of a child with cystic fibrosis.
    Petersen BE; Jenkins SG; Yuan S; Lamm C; Szporn AH
    Pediatr Infect Dis J; 2007 Sep; 26(9):858-9. PubMed ID: 17721390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
    Etherington C; Hall M; Conway S; Peckham D; Denton M
    J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segniliparus rugosus-associated bronchiolitis in California sea lion.
    Evans RH
    Emerg Infect Dis; 2011 Feb; 17(2):311-2. PubMed ID: 21291617
    [No Abstract]   [Full Text] [Related]  

  • 12. Mucoid Inquilinus limosus in a young adult with cystic fibrosis.
    Hayes D; Murphy BS; Kuhn RJ; Anstead MI; Feola DJ
    Pediatr Pulmonol; 2009 Jun; 44(6):619-21. PubMed ID: 19434691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chryseobacterium respiratory tract infections in patients with cystic fibrosis.
    Lambiase A; Del Pezzo M; Raia V; Sepe A; Ferri P; Rossano F
    J Infect; 2007 Dec; 55(6):518-23. PubMed ID: 17889369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis.
    Zebouh M; Thomas C; Honderlick P; Lemee L; Segonds C; Wallet F; Husson MO
    J Cyst Fibros; 2008 May; 7(3):238-43. PubMed ID: 18498727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation.
    Molina A; Del Campo R; Máiz L; Morosini MI; Lamas A; Baquero F; Cantón R
    J Antimicrob Chemother; 2008 Nov; 62(5):961-7. PubMed ID: 18647744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis.
    Spilker T; Liwienski AA; LiPuma JJ
    Clin Microbiol Infect; 2008 May; 14(5):504-6. PubMed ID: 18325036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of macrolide resistance determinants [erm(B) and mef(A)] in Streptococcus pneumoniae and viridans group streptococci (VGS) isolated from adult patients with cystic fibrosis (CF).
    Tazumi A; Maeda Y; Goldsmith CE; Coulter WA; Mason C; Millar BC; McCalmont M; Rendall J; Elborn JS; Matsuda M; Moore JE
    J Antimicrob Chemother; 2009 Sep; 64(3):501-6. PubMed ID: 19584106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
    Moriarty TF; McElnay JC; Elborn JS; Tunney MM
    Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term, low-dose azithromycin treatment reduces the incidence but increases macrolide resistance in Staphylococcus aureus in Danish CF patients.
    Hansen CR; Pressler T; Hoiby N; Johansen HK
    J Cyst Fibros; 2009 Jan; 8(1):58-62. PubMed ID: 18849202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.